WinstonWınston
Thermo Fisher Scientific logo

Thermo Fisher Scientific

TMO
52
Medical - Diagnostics & Research · Healthcare
Winston Score
52
Winston is curious
Mixed quality — meaningful strengths and weaknesses.

Thermo Fisher Scientific makes the tools and equipment that scientists use to do research. Its products include laboratory instruments, chemicals, software, and testing kits used by hospitals, pharmaceutical companies, universities, and government agencies. It is one of the largest suppliers of scientific equipment in the world and owns well-known brands like Fisher Scientific and Thermo Scientific.

The company makes money by selling instruments, consumable supplies, and software, as well as through service contracts on its equipment. It operates globally, with significant revenue from North America, Europe, and Asia, and generates roughly $40 billion in annual revenue. Its main competitive advantage is its enormous product catalog and distribution network, which makes it a one-stop shop for labs. The key risk is that revenue can shrink when pharmaceutical companies cut research budgets or when one-time demand drivers — like COVID-19 testing — fade away.

Winston Score History

Politician Trades

37 trades / 12mo

19 Congressional buys and 18 sells on TMO in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+6.2% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+11.3% YoY

YoY Growth Rate

Steady EPS growth

Insider Activity

0.3%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$3.3B cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Thermo Fisher Scientific is growing revenue at 6% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
40.7%
Healthy — 40.7% gross margin
Operating Margin
16.9%
Healthy — 16.9% operating margin
ROCE
2.0%
Weak — 2.0% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+5.4%
Slow sales growth (5.4% YoY)
EPS YoY
+6.5%
Modest earnings growth (6.5% YoY)

Single-digit earnings growth — steady but not exciting.

EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
121%
Turns 121% of profit into real cash
FCF Margin
14.9%
Converts sales into free cash efficiently (14.9%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.83
Moderate — manageable debt (0.83)
Interest Cover
5.46x
Adequate interest coverage (5.5x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
29.0x
no trend
Growth-priced — P/E 29.0

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
+12.1
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (29.0 → 16.9)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
0.36%
no trend
Small dividend — 0.36% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
+9.8%
no trend
Dividend growing modestly (9.8% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial